Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives

Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives

Background: It is still uncertain whether Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and programmed cell death protein 1 (PD-1) inhibitor have synergistic effects on metastatic soft tissue sarcomas (STSs). The purpose of this study was to evaluate the safety and activity of nab-paclitaxe...

Full description

Bibliographic Details
Main Authors: Zhichao Tian, Yushen Feng, Yang Yang, Xu Liu, Guoxin Qu, Yonghao Yang, Xin Wang, Jiaqiang Wang, Peng Zhang, Weitao Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pharmacology
Subjects:
nab-paclitaxel
camrelizumab
PD-1 inhibitor
sarcoma
immunochemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1335054/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1335054/full

Similar Items